S&P Futures
5,904.50 -1.50 (-0.03%) Dow Futures
43,538.00 +20.00 (+0.05%) Nasdaq Futures
20,460.25 -23.25 (-0.11%) Russell 2000 Futures
2,292.60 +1.40 (+0.06%) Crude Oil
69.62 +0.40 (+0.58%) Gold
2,741.70 +11.70 (+0.43%)
Medigene AG (MDG1.DE)
- GlobeNewswire
Medigene presents UniTope and TraCR a universal detection system for 3S recombinant TCRs at ASGCT 2024
Planegg/Martinsried, October 17, 2024. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an oncology platform company focused on the research and development of T cell receptor (TCR)-guided therapies for the treatment of cancer, presented a universal detection system for 3S (specific, sensitive, and safe) recombinant TCRs (rTCRs), UniTope & TraCR, at the American Society of Gene & Cell Therapy (ASGCT) to be held October 16-17, 2024 in Philadelphia, PA in the US. The presented p
- GlobeNewswire
Medigene to Present at Upcoming Scientific Conferences
Planegg/Martinsried, October 16, 2024. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an oncology platform company focused on the research and development of T cell receptor (TCR)-guided therapies for the treatment of cancer, will present at the 16th Annual Protein & Antibody Engineering Summit (PEGS) to be held from November 5-7, 2024 in Barcelona as well as at the Cell 2024 conference by Oxford Global from November 6-8, 2024 in London. In addition, two posters will be pres
